D. Boral Capital Lowers Nano-X Imaging (NASDAQ:NNOX) Price Target to $10.00

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) had its price objective cut by equities researchers at D. Boral Capital from $15.00 to $10.00 in a report released on Friday,Benzinga reports. The firm presently has a "buy" rating on the stock. D. Boral Capital's price target points to a potential upside of 93.61% from the stock's previous close.

A number of other research analysts also recently issued reports on the company. Alliance Global Partners reissued a "buy" rating on shares of Nano-X Imaging in a research report on Thursday, May 22nd. Cantor Fitzgerald decreased their price target on shares of Nano-X Imaging from $12.00 to $9.00 and set an "overweight" rating for the company in a research note on Tuesday, April 1st.

Nano-X Imaging Price Performance

Shares of Nano-X Imaging stock traded down $0.02 on Friday, hitting $5.17. The company had a trading volume of 599,693 shares, compared to its average volume of 1,734,076. The stock has a 50-day moving average of $5.08 and a 200-day moving average of $6.33. Nano-X Imaging has a twelve month low of $3.75 and a twelve month high of $11.00. The firm has a market capitalization of $298.43 million, a P/E ratio of -6.08 and a beta of 2.03.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported ($0.21) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.02. The firm had revenue of $3.00 million during the quarter, compared to analyst estimates of $3.98 million. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. Equities analysts predict that Nano-X Imaging will post -0.92 EPS for the current year.

Institutional Trading of Nano-X Imaging

A number of hedge funds and other institutional investors have recently modified their holdings of NNOX. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Nano-X Imaging by 232.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company's stock worth $10,793,000 after acquiring an additional 1,510,806 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Nano-X Imaging by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 688,512 shares of the company's stock worth $4,957,000 after purchasing an additional 10,659 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Nano-X Imaging by 71.3% in the 4th quarter. Northern Trust Corp now owns 621,365 shares of the company's stock valued at $4,474,000 after purchasing an additional 258,580 shares during the period. ARK Investment Management LLC raised its holdings in shares of Nano-X Imaging by 19.0% in the 4th quarter. ARK Investment Management LLC now owns 300,757 shares of the company's stock valued at $2,165,000 after purchasing an additional 48,124 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in Nano-X Imaging by 4.6% in the 4th quarter. Bank of New York Mellon Corp now owns 146,551 shares of the company's stock valued at $1,055,000 after purchasing an additional 6,449 shares during the last quarter. Institutional investors and hedge funds own 21.49% of the company's stock.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.